LISA is an information and decision support system developed in collaboration by
Cancer Research UK's Advanced Computation Laboratory,
Information Systems Department and Children's Cancer Group.
This application is intended for use when making oral methotrexate and thiopurine dose decisions
during the maintenance phase of ALL treatment for children on the MRC R3 protocol. It should be used
by clinician's when:
getting decision support upon having obtained a blood result for a child
entering a dose decision to the database
viewing the blood results and dose decisions for the whole of maintenance
finding out which tasks are due on which week during maintenance
N.B. Always log out BEFORE closing the browser window!
